Home » Authors » Kim Coghill

Articles by Kim Coghill

NaPro Selling Paclitaxel Business To Faulding In $72M-Plus Deal

Aug. 27, 2003

NaPro Selling Paclitaxel Business To Faulding In $72M-Plus Deal

Aug. 27, 2003

Amgen Gains Broadened Label For Enbrel In Psoriatic Arthritis

Aug. 26, 2003

Amgen Gains Broadened Label For Enbrel In Psoriatic Arthritis

Aug. 26, 2003

FDA Publishes Action Plan On Steps To Improve Efficiency

Aug. 25, 2003

FDA Publishes Action Plan On Steps To Improve Efficiency

Aug. 25, 2003

Merck Options, Returns Aspects Of Vical's DNA Delivery Platform

Aug. 22, 2003

Merck Options, Returns Aspects Of Vical's DNA Delivery Platform

Aug. 22, 2003

Millennium Ends Broad Alliance With Abbott In Metabolic Disease

Aug. 18, 2003

Millennium Ends Broad Alliance With Abbott In Metabolic Disease

Aug. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...